February 27, 2021
Business News

Shares shrug off U.S. tech sell-off, vaccine trial halt – Reuters

LONDON (Reuters) – European shares on Wednesday shrugged off heavy losses for U.S. tech stocks and a major drugmaker delaying testing of a coronavirus vaccine, as investors kept faith in an economic recovery from the coronavirus pandemic.
The broad Euro STOXX 600 gained 0.7% in early trading, steadying after hefty declines a day earlier on a rout of tech shares, a key drivers of the stunning recovery for global stocks from coronavirus-induced lows.
London shares .FTSE gained 1%, helped by a …

Click here to view the original article.

Related Posts

You might also like ...

AVer Europe: How to Prepare for Hybrid Workspaces
Sixpoint Partners Serves as Exclusive Placement Agent for CORE Industrial Partners Fund II
TEST EW 2021 FEB 27 TEST